DigestRedComo funciona
Red
/
Empresas
Vi
No verificado

Viridian Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosÓpticaSalud

51 Comunicados de prensa

Ver todos los comunicados de prensa
06/08/2026
Mercado de valores
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
26/06/2026
Web y redes sociales
Telefonía
Industria
Biotecnología
Higiene alimentaria
Salud
Óptica
Medicina - Varios
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
27/05/2026
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Eventos
Web y redes sociales
Viridian Therapeutics to Participate in Upcoming June Investor Conferences
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
07/05/2026
Mercado de valores
Acciones y Obligaciones
Asociaciones/Profesionales
Salud
Finanzas
Farmacéutica
Óptica
Biotecnología
Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/05/2026
Mercado de valores
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/05/2026
Web y redes sociales
Eventos
Mercado de valores
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/05/2026
Industria
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
30/03/2026
Web y redes sociales
Telefonía
Industria
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
26/02/2026
Web y redes sociales
Finanzas
Eventos
Mercado de valores
Biotecnología
Salud
Farmacéutica
Óptica
Medicina - Varios
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0
08/01/2026
Salud
Ciencia
Medicina - Varios
Farmacéutica
Biotecnología
Mercado de valores
Finanzas
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fuente
Viridian Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0